+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

EU5 Hematological Disorders Market Outlook to 2036 - Hematology Tests and Hemostasis Tests

  • PDF Icon

    Report

  • 184 Pages
  • May 2026
  • Region: Europe
  • GlobalData
  • ID: 6173491

EU5 Hematological Disorders Market Outlook to 2036 - Hematology Tests and Hemostasis Tests

Summary

The analyst’s “EU5 Hematological Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the EU5 Hematological Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Hematology Tests, Hemostasis Tests

The EU5 Hematological Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Hematological Disorders Market.
  • Global corporate-level profiles of key companies operating within the EU5 Hematological Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Hematological Disorders is segmented as follows:

  • Hematology Tests
  • Hemostasis Tests

Reasons to Buy

The EU5 Hematological Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Hematological Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hematological Disorders Market, EU5
2.1 Hematological Disorders Market, EU5, Revenue ($m), 2024-2036
2.2 Hematological Disorders Market, EU5, Revenue ($m), 2024-2036
2.3 Hematological Disorders Market, EU5, Volume (Units), 2024-2036
2.4 Hematological Disorders Market, EU5, Volume (Units), 2024-2036
2.5 Hematological Disorders Market, EU5, Company Share by Revenue ($m), 2025
3 Hematological Disorders Market, France
3.1 Hematological Disorders Market, France, Revenue ($m), 2024-2036
3.1.1 Hematology Tests Market, France, Revenue ($m), by Segment, 2024-2036
3.1.2 Hemostasis Tests Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Hematological Disorders Market, France, Volume (Units), 2024-2036
3.2.1 Hematology Tests Market, France, Volume (Units), by Segment, 2024-2036
3.2.2 Hemostasis Tests Market, France, Volume (Units), by Segment, 2024-2036
3.3 Hematological Disorders Market, France, Average Price ($), 2024-2036
3.4 Hematological Disorders Market, France, Company Share by Revenue ($m), 2025
4 Hematological Disorders Market, Germany
4.1 Hematological Disorders Market, Germany, Revenue ($m), 2024-2036
4.1.1 Hematology Tests Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.2 Hemostasis Tests Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Hematological Disorders Market, Germany, Volume (Units), 2024-2036
4.2.1 Hematology Tests Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.2 Hemostasis Tests Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Hematological Disorders Market, Germany, Average Price ($), 2024-2036
4.4 Hematological Disorders Market, Germany, Company Share by Revenue ($m), 2025
5 Hematological Disorders Market, Italy
5.1 Hematological Disorders Market, Italy, Revenue ($m), 2024-2036
5.1.1 Hematology Tests Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.2 Hemostasis Tests Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Hematological Disorders Market, Italy, Volume (Units), 2024-2036
5.2.1 Hematology Tests Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.2 Hemostasis Tests Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Hematological Disorders Market, Italy, Average Price ($), 2024-2036
5.4 Hematological Disorders Market, Italy, Company Share by Revenue ($m), 2025
6 Hematological Disorders Market, Spain
6.1 Hematological Disorders Market, Spain, Revenue ($m), 2024-2036
6.1.1 Hematology Tests Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.2 Hemostasis Tests Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Hematological Disorders Market, Spain, Volume (Units), 2024-2036
6.2.1 Hematology Tests Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.2 Hemostasis Tests Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Hematological Disorders Market, Spain, Average Price ($), 2024-2036
6.4 Hematological Disorders Market, Spain, Company Share by Revenue ($m), 2025
7 Hematological Disorders Market, United Kingdom
7.1 Hematological Disorders Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Hematology Tests Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.2 Hemostasis Tests Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Hematological Disorders Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Hematology Tests Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.2 Hemostasis Tests Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Hematological Disorders Market, United Kingdom, Average Price ($), 2024-2036
7.4 Hematological Disorders Market, United Kingdom, Company Share by Revenue ($m), 2025
8 Hematological Disorders Market Pipeline Products
8.1 Hematological Disorders Market Pipeline Products
8.2 Hematological Disorders - Pipeline Products by Stage of Development
8.3 Hematological Disorders - Pipeline Products by Segment
8.4 Hematological Disorders - Pipeline Products by Territory
8.5 Hematological Disorders - Pipeline Products by Regulatory Path
8.6 Hematological Disorders - Pipeline Products by Estimated Approval Date
9 Overview of Key Companies in EU5 Hematological Disorders Market
9.1 Roche Diagnostics International Ltd
9.1.1 Company Overview
9.2 Sysmex Corp
9.2.1 Company Overview
9.3 Abbott Laboratories
9.3.1 Company Overview
9.4 Diagnostica Stago SAS
9.4.1 Company Overview
9.5 Instrumentation Laboratory Co
9.5.1 Company Overview
9.6 Siemens AG
9.6.1 Company Overview
9.7 Horiba Ltd
9.7.1 Company Overview
9.8 Radiometer Medical ApS
9.8.1 Company Overview
10 Recent Developments
10.1 Corporate Communications
10.1.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.2 Oct 24, 2025: EU Invests in Umeå Research
10.1.3 Oct 08, 2025: Virogates A/S Announces Public Tender Offer to Shareholders
10.1.4 Sep 15, 2025: Mdxhealth Completes Acquisition of Exosome Diagnostics from Bio-Techne
10.1.5 Sep 15, 2025: Major £1.9 Million Investment Brings Microscopy Facility to Birkbeck
10.1.6 Sep 11, 2025: Navignostics Chosen as Finalist for 2025 Swiss Technology Award
10.2 Financial Announcements
10.2.1 Feb 05, 2026: Siemens Healthineers Announces Q1 Results for Fiscal Year 2026
10.2.2 Sep 10, 2025: EKF Diagnostics: Notice of Interim Results
10.3 Other Significant Developments
10.3.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.3.2 Nov 05, 2025: New CIRSE Group Member: The Saudi Interventional Radiology Society
10.3.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.3.4 Oct 24, 2025: EU Invests in Umeå Research
10.3.5 Oct 08, 2025: Virogates A/S Announces Public Tender Offer to Shareholders
10.4 Product News
10.4.1 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
10.4.2 Nov 14, 2025: Scientists Invent New Method for Producing Platelet-Producing Cells from Stem Cells
10.4.3 Nov 12, 2025: Unique Immune Signatures Distinguish MOGAD from MS
10.4.4 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.4.5 Oct 30, 2025: FNCC RR Showcases Innovative Developments at All-Russian Exhibition
10.4.6 Oct 17, 2025: S4DX Launches First UK Pilot to Enhance Blood Diagnostics
10.5 Research And Development
10.5.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.6 Strategy And Business Planning
10.6.1 Nov 17, 2025: UMA Joins Technological Platforms to Boost Innovation
10.6.2 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.6.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.6.4 Oct 22, 2025: HMI Medical Expands Imaging Services in Singapore
10.6.5 Oct 14, 2025: START, Together With HM Hospitales, Inaugurates Spain’s First Pediatric Onco-Hematology Clinical Research Unit
10.6.6 Oct 02, 2025: AIxMed And Biopticka Laborator Announce Strategic Collaboration On AI-Cytology In Europe
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the Analyst Consulting
11.3 Contact Us
11.4 Disclaimer
List of Tables
Table 1: Hematological Disorders Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Table 2: Hematological Disorders Market, EU5, Revenue ($m), USD Constant, 2024-2036
Table 3: Hematological Disorders Market, EU5, Volume (Units), 2024-2036
Table 4: Hematological Disorders Market, EU5, Volume (Units), 2024-2036
Table 5: Hematological Disorders Market, EU5, Company Share by Revenue ($m), 2025
Table 6: Hematological Disorders Market, France, Revenue ($m), USD Constant, 2024-2036
Table 7: Hematology Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Table 8: Hemostasis Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Table 9: Hematological Disorders Market, France, Volume (Units), 2024-2036
Table 10: Hematology Tests Market, France, Volume (Units), 2024-2036
Table 11: Hemostasis Tests Market, France, Volume (Units), 2024-2036
Table 12: Hematological Disorders Market, France, Average Price ($), 2024-2036
Table 13: Hematological Disorders Market, France, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Hematological Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 15: Hematology Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 16: Hemostasis Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 17: Hematological Disorders Market, Germany, Volume (Units), 2024-2036
Table 18: Hematology Tests Market, Germany, Volume (Units), 2024-2036
Table 19: Hemostasis Tests Market, Germany, Volume (Units), 2024-2036
Table 20: Hematological Disorders Market, Germany, Average Price ($), 2024-2036
Table 21: Hematological Disorders Market, Germany, Company Share by Revenue ($m), USD Constant, 2025
Table 22: Hematological Disorders Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 23: Hematology Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 24: Hemostasis Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 25: Hematological Disorders Market, Italy, Volume (Units), 2024-2036
Table 26: Hematology Tests Market, Italy, Volume (Units), 2024-2036
Table 27: Hemostasis Tests Market, Italy, Volume (Units), 2024-2036
Table 28: Hematological Disorders Market, Italy, Average Price ($), 2024-2036
Table 29: Hematological Disorders Market, Italy, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Hematological Disorders Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 31: Hematology Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 32: Hemostasis Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 33: Hematological Disorders Market, Spain, Volume (Units), 2024-2036
Table 34: Hematology Tests Market, Spain, Volume (Units), 2024-2036
Table 35: Hemostasis Tests Market, Spain, Volume (Units), 2024-2036
Table 36: Hematological Disorders Market, Spain, Average Price ($), 2024-2036
Table 37: Hematological Disorders Market, Spain, Company Share by Revenue ($m), USD Constant, 2025
Table 38: Hematological Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 39: Hematology Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 40: Hemostasis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 41: Hematological Disorders Market, United Kingdom, Volume (Units), 2024-2036
Table 42: Hematology Tests Market, United Kingdom, Volume (Units), 2024-2036
Table 43: Hemostasis Tests Market, United Kingdom, Volume (Units), 2024-2036
Table 44: Hematological Disorders Market, United Kingdom, Average Price ($), 2024-2036
Table 45: Hematological Disorders Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025
Table 46: Hematological Disorders Market Pipeline Products
Table 47: Hematological Disorders - Pipeline Products by Stage of Development
Table 48: Hematological Disorders Companies - Pipeline Products by Stage of Development
Table 49: Hematological Disorders - Pipeline Products by Segment
Table 50: Hematological Disorders - Pipeline Products by Territory
Table 51: Hematological Disorders - Pipeline Products by Regulatory Path
Table 52: Hematological Disorders - Pipeline Products by Estimated Approval Date
Table 53: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hematological Disorders Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hematological Disorders Market, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hematological Disorders Market, EU5, Volume (Units), 2024-2036
Figure 4: Hematological Disorders Market, EU5, Volume (Units), 2024-2036
Figure 5: Hematological Disorders Market, EU5, Company Share (%), 2025
Figure 6: Hematological Disorders Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 7: Hematology Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 8: Hemostasis Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 9: Hematological Disorders Market, France, Volume (Units), 2024-2036
Figure 10: Hematology Tests Market, France, Volume (Units), 2024-2036
Figure 11: Hemostasis Tests Market, France, Volume (Units), 2024-2036
Figure 12: Hematological Disorders Market, France, Company Share (%), 2025
Figure 13: Hematological Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 14: Hematology Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 15: Hemostasis Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 16: Hematological Disorders Market, Germany, Volume (Units), 2024-2036
Figure 17: Hematology Tests Market, Germany, Volume (Units), 2024-2036
Figure 18: Hemostasis Tests Market, Germany, Volume (Units), 2024-2036
Figure 19: Hematological Disorders Market, Germany, Company Share (%), 2025
Figure 20: Hematological Disorders Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 21: Hematology Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 22: Hemostasis Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 23: Hematological Disorders Market, Italy, Volume (Units), 2024-2036
Figure 24: Hematology Tests Market, Italy, Volume (Units), 2024-2036
Figure 25: Hemostasis Tests Market, Italy, Volume (Units), 2024-2036
Figure 26: Hematological Disorders Market, Italy, Company Share (%), 2025
Figure 27: Hematological Disorders Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 28: Hematology Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 29: Hemostasis Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 30: Hematological Disorders Market, Spain, Volume (Units), 2024-2036
Figure 31: Hematology Tests Market, Spain, Volume (Units), 2024-2036
Figure 32: Hemostasis Tests Market, Spain, Volume (Units), 2024-2036
Figure 33: Hematological Disorders Market, Spain, Company Share (%), 2025
Figure 34: Hematological Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 35: Hematology Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 36: Hemostasis Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 37: Hematological Disorders Market, United Kingdom, Volume (Units), 2024-2036
Figure 38: Hematology Tests Market, United Kingdom, Volume (Units), 2024-2036
Figure 39: Hemostasis Tests Market, United Kingdom, Volume (Units), 2024-2036
Figure 40: Hematological Disorders Market, United Kingdom, Company Share (%), 2025
Figure 41: Hematological Disorders - Pipeline Products by Stage of Development
Figure 42: Hematological Disorders - Pipeline Products by Segment
Figure 43: Hematological Disorders - Pipeline Products by Territory
Figure 44: Hematological Disorders - Pipeline Products by Regulatory Path
Figure 45: Hematological Disorders - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Roche Diagnostics International Ltd
  • Sysmex Corp
  • Abbott Laboratories
  • Diagnostica Stago SAS
  • Instrumentation Laboratory Co
  • Siemens AG
  • Horiba Ltd
  • Radiometer Medical ApS